Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product
- PMID: 12913071
- DOI: 10.1093/hmg/ddg214
Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product
Abstract
Mutations of the WFS1 gene are responsible for Wolfram syndrome, a rare, recessive disorder characterized by early-onset, non-autoimmune diabetes mellitus, optic atrophy and further neurological and endocrinological abnormalities. The WFS1 gene encodes wolframin, a putative multispanning membrane glycoprotein of the endoplasmic reticulum. The function of wolframin is completely unknown. In order to characterize wolframin, we have generated polyclonal antibodies against both hydrophilic termini of the protein. Wolframin was found to be ubiquitously expressed with highest levels in brain, pancreas, heart and insulinoma beta-cell lines. Analysis of the structural features provides experimental evidence that wolframin contains nine transmembrane segments and is embedded in the membrane in an N(cyt)/C(lum) topology. Wolframin assembles into higher molecular weight complexes of approximately 400 kDa in the membrane. Pulse-chase experiments demonstrate that during maturation wolframin is N-glycosylated but lacks proteolytical processing. Moreover, N-glycosylation appears to be essential for the biogenesis and stability of wolframin. Here we investigate, for the first time, the molecular mechanisms that cause loss-of-function of wolframin in affected individuals. In patients harboring nonsense mutations complete absence of the mutated wolframin is caused by instability and rapid decay of WFS1 nonsense transcripts. In a patient carrying a compound heterozygous missense mutation, R629W, we found markedly reduced steady-state levels of wolframin. Pulse-chase experiments of mutant wolframin expressed in COS-7 cells indicated that the R629W mutation leads to instability and strongly reduced half-life of wolframin. Thus, the Wolfram syndrome in patients investigated here is caused by reduced protein dosage rather than dysfunction of the mutant wolframin.
Similar articles
-
Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin.FEBS Lett. 2006 Jul 10;580(16):4000-4. doi: 10.1016/j.febslet.2006.06.036. Epub 2006 Jun 22. FEBS Lett. 2006. PMID: 16806192
-
A novel mutation of WFS1 gene leading to increase ER stress and cell apoptosis is associated an autosomal dominant form of Wolfram syndrome type 1.BMC Endocr Disord. 2021 Apr 21;21(1):76. doi: 10.1186/s12902-021-00748-z. BMC Endocr Disord. 2021. PMID: 33879153 Free PMC article.
-
A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome.J Pediatr Endocrinol Metab. 2016 May 1;29(5):607-9. doi: 10.1515/jpem-2015-0045. J Pediatr Endocrinol Metab. 2016. PMID: 26943604
-
[Wolfram syndrome: from definition to molecular bases].Arq Bras Endocrinol Metabol. 2006 Oct;50(5):839-44. doi: 10.1590/s0004-27302006000500003. Arq Bras Endocrinol Metabol. 2006. PMID: 17160206 Review. Portuguese.
-
[From gene to disease; mutations in the WFS1-gene as the cause of juvenile type I diabetes mellitus with optic atrophy (Wolfram syndrome)].Ned Tijdschr Geneeskd. 2002 May 25;146(21):985-7. Ned Tijdschr Geneeskd. 2002. PMID: 12058630 Review. Dutch.
Cited by
-
A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.Diabetologia. 2025 Jan;68(1):128-151. doi: 10.1007/s00125-024-06307-0. Epub 2024 Nov 9. Diabetologia. 2025. PMID: 39520565 Free PMC article.
-
Insights from a Wolfram syndrome cohort: clinical and molecular findings from a specialized diabetes reference center.Arch Endocrinol Metab. 2024 Sep 24;68:e240091. doi: 10.20945/2359-4292-2024-0091. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39420940 Free PMC article.
-
Wolfram Syndrome 1: A Neuropsychiatric Perspective on a Rare Disease.Genes (Basel). 2024 Jul 25;15(8):984. doi: 10.3390/genes15080984. Genes (Basel). 2024. PMID: 39202345 Free PMC article. Review.
-
Clinical Characteristics and Audiological Profiles of Patients with Pathogenic Variants of WFS1.J Clin Med. 2024 Aug 16;13(16):4851. doi: 10.3390/jcm13164851. J Clin Med. 2024. PMID: 39200993 Free PMC article.
-
A deep phenotyping study in mouse and iPSC models to understand the role of oligodendroglia in optic neuropathy in Wolfram syndrome.Acta Neuropathol Commun. 2024 Aug 28;12(1):140. doi: 10.1186/s40478-024-01851-7. Acta Neuropathol Commun. 2024. PMID: 39198924 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous